Literature DB >> 12856232

Tuberculosis due to Mycobacterium bovis after alemtuzumab administration.

S Abad1, E Gyan, L Moachon, D Bouscary, D Sicard, F Dreyfus, P Blanche.   

Abstract

We describe a patient with relapsing B chronic lymphocytic leukemia who developed systemic bacille Calmette-Guérin infection (BCGitis) after administration of alemtuzumab (Campath-1H).

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12856232     DOI： 10.1086/375690

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  3 in total

Review 1.  Current landscape for T-cell targeting in autoimmunity and transplantation.

Authors:  Daniel R Getts; Sushma Shankar; Emily M L Chastain; Aaron Martin; Meghann Teague Getts; Kathryn Wood; Stephen D Miller
Journal:  Immunotherapy       Date:  2011-07       Impact factor: 4.196

Review 2.  Infectious complications associated with monoclonal antibodies and related small molecules.

Authors:  Edsel Maurice T Salvana; Robert A Salata
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

3.  Mycobacterium haemophilum infection after alemtuzumab treatment.

Authors:  Mini Kamboj; Eddie Louie; Timothy Kiehn; Genovefa Papanicolaou; Michael Glickman; Kent Sepkowitz
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.